As observed in Figure 5A‐B, PRMT5 knockdown decreased the phosphorylation level of EGFR (at Y1068 and Y1172) in pancreatic cancer cells, while ectopic PRMT5 re‐expression reversed these changes. This evidence concerns the gene EGFR and familial pancreatic carcinoma.